U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07526506) titled 'Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers' on April 06.
Brief Summary: This is a Phase 1b, randomized, double-blind, placebo-controlled, dose escalation study of TRX-100 tablets evaluating the safety, pharmacokinetics, and food effect of single ascending doses of TRX-100 in healthy volunteers.
Study Start Date: March 25
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: TRX-100 or placebo
The patient will receive TRX-100 or placebo
Recruitment Status: RECRUITING
Sponsor: Traws Pharma, Inc.
Disclaimer: Curated by HT Syndication....